federal_register: 2017-26440
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts | regulation_id_numbers |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-26440 | Oncology Center of Excellence Listening Session; Public Meeting; Request for Comments | Notice | The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Oncology Center of Excellence (OCE): Listening Session." The purpose of the public meeting and the docket for comments is for stakeholders to provide recommendations to the Agency regarding FDA's OCE. Specifically, the Agency solicits comments regarding what stakeholders desire of the OCE in terms of structure, function, regulatory purview, and activity. | 2017-12-08 | 2017 | 12 | https://www.federalregister.gov/documents/2017/12/08/2017-26440/oncology-center-of-excellence-listening-session-public-meeting-request-for-comments | https://www.govinfo.gov/content/pkg/FR-2017-12-08/pdf/2017-26440.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Oncology Center of Excellence (OCE): Listening Session." The purpose of the public meeting and the docket for comments is for stakeholders to... |